한글목차

생검 기기 동향 및 전망

세계 생검 기기 시장은 2024년부터 2030년까지 6.6%의 CAGR로 2030년까지 약 37억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 암 발병률 증가와 최소침습적 시술에 대한 수요 증가입니다. 세계 생검 기기 시장의 미래는 유방 생검, 폐 생검, 대장 생검, 전립선 생검 시장의 기회로 인해 유망합니다.

• Lucintel의 예측에 따르면, 제품 범주에서 바늘 생검 기기는 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.
• 용도별로는 유방 생검이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.

생검 기기 시장의 전략적 성장 기회

기술 개발과 헬스케어 수요 증가로 생검 기기 시장은 여러 응용 분야에 걸쳐 다양한 성장 기회를 제공하고 있습니다. 이러한 기회는 업계의 개선 및 확장 가능성을 강조합니다.

• 암 진단 분야의 성장 : 암 환자 수가 증가함에 따라 암의 조기 발견율을 높이기 위한 첨단 생검 기기의 필요성이 대두되고 있습니다. 이러한 기회에는 시술의 위험을 줄이면서 정확도를 높이는 새로운 기술의 도입과 종양 집단을 표적으로 삼을 수 있는 더 나은 방법이 포함됩니다. 이 성장 분야는 암을 더 잘 통제하고 관리하기 위해 필수적인 분야입니다.
• 휴대용 솔루션 개발 : 휴대가 간편하고 저렴한 생검 기기의 출현은 특히 저소득층에서 큰 성장 잠재력을 보여주고 있습니다. 더 작고 비용 효율적인 장비의 기술 발전은 생검의 활용도를 높여 의료 서비스 격차를 해소하고 다양한 인구 집단에서 질병을 조기에 발견할 수 있도록 하는 데 필수적입니다.
• 디지털 건강 플랫폼과의 통합 : 무선 생검 장치를 원격의료 및 전자 의료 기록을 포함한 디지털 건강 기반에 통합하면 환자 치료, 모니터링 및 진단을 향상시킬 수 있는 기회를 제공할 수 있습니다. 이러한 애플리케이션은 진료 사이사이에 데이터 수집을 가능하게 하고, 임상 간 협업을 개선할 수 있도록 돕습니다.
• 최소침습적 기술 : 통증과 치료 시간을 줄여주는 비침습적 생검 기술에 대한 수요가 눈에 띄게 증가하고 있습니다. 바늘을 사용하지 않는 생검 시스템 및 스네어 기술을 강화하여 임상 현장에서 환자 경험을 개선할 수 있는 기회가 분명히 존재합니다.
• 로봇 보조 생검의 발전 : 로봇 팔로 생검을 용이하게 하는 시스템의 성장 기회는 이러한 시스템의 정확성을 향상시킬 수 있는 기회를 부각시키고 있습니다. 로봇 기술은 진단 및 치료에서 우려되는 장기를 정확하게 파악할 수 있어 기존 치료의 부작용을 줄여 환자 치료를 개선하고 병원에서 로봇 기술의 폭넓은 채택을 촉진할 수 있습니다.

이러한 전략은 생검 기기 시장에서 더 많은 혁신과 강화를 달성할 수 있는 방법을 제시합니다. 암 진단, 휴대용 기기, 디지털 건강, 최소침습 전략, 로봇 시스템의 발전에 초점을 맞추면 새로운 기회를 창출하고 고객 만족도를 높이며 경제 발전을 촉진할 수 있습니다.

생검 기기 시장의 촉진요인 및 과제

생검 기기 시장은 다양한 기술적, 경제적, 규제적 촉진요인 및 과제에 의해 큰 영향을 받고 있습니다. 기술 개발은 보다 정확하고 빠른 생검으로 이어지고 있습니다. 경제적 요인은 지리적 접근 및 시장 성장과 관련이 있습니다. 법적 문제는 새로운 장치의 생성 및 생산에 영향을 미칩니다.

생검 기기 시장을 이끄는 주요 요인은 다음과 같습니다.

• 기술적 요인 : 기술 발전은 생검 기기 시장의 주요 촉진요인으로, AI 이미지 해석, 로봇 보조 수술, 개선된 영상 양식과 같은 획기적인 기술은 생검 절차의 속도와 정확성을 향상시키는 동시에 최소침습을 가능하게 합니다. 이러한 기술은 보다 정확한 조직 샘플링과 효과적인 진단을 가능하게 하고, 생검 절차에서 첨단 의료기기의 사용을 증가시킬 수 있습니다. 지속적인 기술 발전은 생검 기기의 기능을 확장하고 그 용도를 넓힐 것으로 예상됩니다.
• 암 환자 증가 : 암 발병률의 증가는 더 나은 생검 기기에 대한 수요를 주도하고 있습니다. 효과적인 치료를 위해 조기에 정확하게 발견하는 것이 중요해지고 있습니다. 첨단 생검 기술의 필요성은 장비의 성능 향상과 암 진단의 효율성 향상을 촉진하고 있습니다. 암 유병률의 증가로 인해 업계의 수요를 충족시킬 수 있는 새로운 생검 기술 개발이 요구되고 있습니다.
• 최소침습적 치료에 대한 선호도 : 최소침습적 시술은 생검 기기 시장의 성장에 영향을 미칩니다. 무침 생검 및 내시경 생검과 같은 기술은 진단의 질을 떨어뜨리지 않으면서도 환자의 편의성을 높이고 회복 시간을 단축합니다. 이러한 최소침습화 추세는 환자 경험을 개선하고 생검의 용도를 확대하는 새로운 기술의 도입으로 이어지고 있습니다.

생검 기기 시장의 과제는 다음과 같습니다.

• 첨단 장비가 비싸다 : 특히 신흥국에서는 기술 장벽이 새로 도입되는 생검 기기의 보급을 방해하고 있습니다. 첨단 기술의 개발 및 생산에는 많은 비용이 소요되며, 이는 결국 최종사용자에게 전가됩니다. 이러한 문제는 첨단 생검 기기의 시장 침투에 영향을 미치고 특정 지역 및 의료 상황에서 사용을 제한 할 수 있습니다.
• 규제 문제 : 규제 장벽은 새로운 생검 기기의 발전을 저해할 수 있습니다. 지역마다 사양과 요구사항이 다르기 때문에 신기술 도입이 지연될 수 있습니다. 규제 대응은 장비의 안전성과 유효성을 위해 필수적이지만, 비용과 시간이 많이 소요될 수 있습니다. 규제 문제로 인해 첨단 생검 기기가 사용자에게 신속하게 제공되지 못할 수 있습니다.
• 데이터 프라이버시 및 보안 문제 : 환자 데이터를 수집하는 생검 기기와 시스템은 프라이버시 및 보안 문제를 해결해야 합니다. 사회적 데이터와 병력을 포함한 기밀 정보를 보호하고, 환자의 기밀성을 유지하며, 개인정보 보호 규정을 준수하는 것이 매우 중요합니다. 이러한 과제는 보안 조치 강화와 데이터 보호 규정 준수를 요구하며, 생검 기기의 제조 및 도입을 복잡하게 만들고 있습니다.

목차

제1장 주요 요약

제2장 세계의 생검 기기 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 생검 기기 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품별 세계의 생검 기기 시장
  • 침생검 기기
  • 로컬라이제이션 와이어
  • 시술 트레이
  • 기타
• 가이던스 방법별 세계의 생검 기기 시장
  • 초음파 유도하 생검
  • 정위 유도하 생검
  • MRI 유도하 생검
  • 기타
• 용도별 세계의 생검 기기 시장
  • 유방 생검
  • 폐 생검
  • 대장 생검
  • 전립선 생검
  • 기타
• 최종 용도별 세계의 생검 기기 시장
  • 병원
  • 학술조사기관
  • 진단·영상 진단 센터

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 생검 기기 시장
• 북미의 생검 기기 시장
• 유럽의 생검 기기 시장
• 아시아태평양 생검 기기 시장
• 기타 지역 생검 기기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품별 성장 기회
  • 가이던스 방법별 성장 기회
  • 용도별 성장 기회
  • 최종 용도별 성장 기회
  • 지역별 성장 기회
• 세계의 생검 기기 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 생검 기기 시장 능력 확대
  • 세계의 생검 기기 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Cook Medical
• Boston Scientific
• Fujifilm
• Cardinal Health
• Danaher

영문목차

Biopsy Device Trends and Forecast

The future of the global biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets. The global biopsy device market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of cancer and the increasing demand for minimally invasive procedures.

• Lucintel forecasts that, within the product category, needle-based biopsy instrument is expected to witness the highest growth over the forecast period.
• Within the application category, breast biopsy is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biopsy Device Market

Like any other market, the biopsy device market is changing in several ways due to the emergence of key trends and shifts in the financial industry. These trends are defining the future of biopsy techniques and their applications.

• Integration of Artificial Intelligence: The incorporation of AI in biopsy devices is aiding in achieving accurate diagnoses through efficient analysis of image data and characterization of tissues. Vast amounts of data can be analyzed by AI models, patterns can be established, and abnormalities that would ordinarily go unnoticed can be flagged. These trends aim to provide more accurate and precise outcomes from biopsy procedures, minimizing the likelihood of misdiagnosis and enhancing patient health.
• Techniques that are Less Severely Invasive: There is an increasing focus on less invasive biopsy techniques to alleviate pain and reduce recovery time for patients. New developments, such as needleless biopsies and more sophisticated endoscopic techniques, are decreasing the invasiveness of procedures without compromising diagnostic quality. This shift enhances patient experience and broadens the scope of biopsies in various clinical contexts.
• Core Biopsy Synthesis with Imaging Techniques: New imaging technologies, such as real-time ultrasound and MRI, which were previously external to biopsy systems, are now being integrated into biopsy devices to improve targeting and accuracy. These integrations enhance target tissue visualization, augmenting the efficiency of tissue sampling and limiting risks associated with procedures. This development is making biopsies increasingly efficient and improving diagnoses.
• Mobile and Affordable Devices: The technology is moving toward the development of small, affordable biopsy devices that are easy to use at the point of care. The reduction in size and cost of technology facilitates biopsy performance in various locations and addresses imbalances in healthcare systems by improving rates of early identification and diagnosis among different demographics.
• Robotic-Assisted Biopsies: Robotic-assisted systems are providing necessary measures of accuracy and intervention during biopsy processes. These systems increase the precision of tissue sampling and reduce the chances of human error. The use of robotics is making biopsies more standardized and accurate, thereby improving the efficiency and effectiveness of procedures and enhancing patient outcomes.

The current trends in the biopsy device market are aimed at improving accuracy, safety, and ease of use. The integration of AI, less invasive approaches, imaging technologies, compact size, and robotics technology is enhancing productivity and revolutionizing biopsy technologies, thus improving the quality of diagnosis and healthcare.

Recent Developments in the Biopsy Device Market

Recent developments in the biopsy device market highlight significant advancements that make biopsy procedures more accurate, easier, and effective. These improvements are driven by technological growth in medicine and healthcare.

• Artificial Intelligence for Image Diagnostics: AI is penetrating the biopsy device arena to advance diagnostic accuracy. Sophisticated algorithms process images acquired from biopsies to detect and classify tissue lesions accurately. This step reduces the incidence of diagnostic failures and ensures findings are of appropriate quality, enhancing patient care and improving treatment choices.
• Development of Robotic Systems: The enhancement of robotic systems in biopsy procedures is ongoing. These advanced systems are more effective in tissue sampling and minimizing factors associated with human error. By taking over the most complicated aspects of biopsies, robotic systems enhance the reproducibility and reliability of outcomes, which in turn facilitates better diagnosis and treatment of diseases.
• Consideration for Less Painful Biopsy Types: Applying minimally invasive biopsy techniques decreases patient suffering and healing time. More efficient methods, such as needleless biopsies and endoscopic approaches, are reducing the invasiveness of procedures without compromising diagnostic effectiveness. These improvements contribute to better patient care and expand indications for biopsies in various clinical practices.
• Biopsy Miniaturization and Development of Portable Biopsy Devices: Portable biopsy devices are transforming the landscape of biopsy procedures, even in rural and underserved regions. These devices are small, and affordable, and provide services usually unavailable in clinics, reducing the need for travel for medical attention.
• Real-Time Imaging Integration: Improved integration of real-time imaging systems, such as ultrasound or MRI, with biopsy devices is increasing procedural accuracy. Real-time imaging enhances visualization of the site of interest, facilitating better sampling and reducing risks associated with procedures. This development leads to increased efficacy and accuracy of biopsies.

These novel changes are revolutionizing the biopsy device market, making procedures more effective, less invasive, and easier to access. The incorporation of AI, robotic systems, minimally invasive approaches, portability, and real-time imaging are all factors shaping progress and enhancing the effectiveness of biopsy procedures.

Strategic Growth Opportunities for Biopsy Device Market

In the context of technological developments and increasing healthcare demands, the biopsy device market offers numerous growth areas across several applications. These opportunities highlight the potential for improvement and expansion in the industry.

• Growth in Cancer Diagnostics: The rising number of cancer cases necessitates advanced biopsy devices to improve early cancer detection rates. Opportunities include introducing new technologies that enhance accuracy while decreasing procedural risks, as well as better methods of targeting tumor populations. This growth area is vital for enhancing cancer control and management.
• Development of Portable Solutions: The emergence of portable and affordable biopsy devices presents significant growth potential, especially in low-income areas. Technological advancements in smaller, cost-effective devices are essential for increasing biopsy utilization rates, thereby closing gaps in healthcare services and enabling early disease detection across various populations.
• Integration with Digital Health Platforms: Integrating wireless biopsy instruments into digital health infrastructures, including telehealth and electronic personal health records, presents opportunities for enriching patient care, monitoring, and diagnostics. These applications enable data collection between visits and facilitate improved inter-clinical collaboration.
• Minimally Invasive Technologies: There has been a notable increase in the demand for non-intrusive biopsy techniques that reduce pain and healing times. There are clear opportunities to enhance needle-free biopsy systems and snare techniques, improving patient experiences in clinical settings.
• Advancements in Robotic-Assisted Biopsies: The growth of systems that facilitate biopsy procedures through robotic arms highlights opportunities for improving the accuracy of these systems. Robotic technology can accurately target the organ of concern during diagnosis and treatment, thereby improving patient care by reducing side effects associated with previous treatments and encouraging wider adoption of robotics in hospitals.

These strategies suggest how further innovations and enhancements can be achieved in the biopsy device market. Focusing on advances in cancer diagnostics, portable devices, digital health, minimally invasive strategies, and robotic systems will entrench new opportunities, enhance customer satisfaction, and promote economic development.

Biopsy Device Market Driver and Challenges

The biopsy device market is significantly impacted by various technological, economic, and regulatory drivers and challenges. Technological developments are leading to more accurate and faster biopsies. Economic factors are linked to geographical access and market growth. Legal concerns influence the creation and production of new devices.

The key factors driving the biopsy device market include:

• Technological Factors: Technological advancements are key drivers in the biopsy device market. Breakthroughs such as AI image interpretation, robot-assisted surgery, and improved imaging modalities enhance the speed and accuracy of biopsy procedures while making them minimally invasive. Such technologies allow for more precise tissue sampling and effective diagnosis, leading to increased utilization of sophisticated medical equipment in biopsy procedures. Ongoing technological advancements are expected to expand the functions of biopsy devices and broaden their applications.
• Increasing Cases of Cancer: The rising incidence of cancer is driving demand for better biopsy devices. There is a growing emphasis on early and accurate detection for effective treatment. The need for advanced biopsy technologies is prompting improvements in device performance and effectiveness in cancer diagnosis. The increasing prevalence of cancer necessitates the development of new biopsy technologies to meet industry demand.
• Preference for Minimally Invasive Procedures: Minimally invasive procedures influence the growth of the biopsy device market. Techniques such as needle-free and endoscopic biopsies enhance patient comfort and shorten recovery times without compromising diagnostic quality. This trend toward reduced invasiveness is leading to the introduction of new technologies that improve patient experiences and widen the applications for biopsies.

Challenges in the biopsy device market include:

• Advanced Devices Are Expensive: Technology barriers hinder the uptake of newly introduced biopsy devices, particularly in developing countries. There is a significant cost associated with the development and production of cutting-edge technologies, which is ultimately passed on to the end user. These challenges affect the market penetration of advanced biopsy devices and may restrict their use in certain geographical or medical contexts.
• Regulatory Issues: Regulatory hurdles can impede the progress of new biopsy devices. The diverse specifications and requirements across regions can delay the introduction of new technologies. While addressing regulations is essential for the safety and effectiveness of devices, it can also be costly and time-consuming. Regulatory issues may limit the rapid access of advanced biopsy devices to users.
• Data Privacy and Security Concerns: Biopsy devices and systems that collect patient data must address privacy and security issues. It is crucial to protect sensitive information, including social data and medical histories, to maintain patient confidentiality and comply with privacy regulations. These challenges necessitate enhanced security measures and compliance with data protection regulations, complicating the manufacturing and introduction of biopsy devices.

Factors such as the growth of innovative technologies, increasing cancer rates, rising interest in non-invasive procedures, a burgeoning market for personalized medicine, and improved healthcare infrastructure are promoting growth in the biopsy device market. However, challenges such as high costs, regulatory barriers, and data privacy concerns must be addressed to facilitate technology acceptance and operational efficiency. Striking a balance between innovation and these hurdles is vital for advancing biopsy procedures while safeguarding patient interests.

List of Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopsy device companies profiled in this report include-

• Cook Medical
• Boston Scientific
• Fujifilm
• Cardinal Health
• Danaher

Biopsy Device by Segment

The study includes a forecast for the global biopsy device by product, guidance technique, application, end use, and region.

Biopsy Device Market by Product [Analysis by Value from 2018 to 2030]:

• Needle-Based Biopsy Devices
• Localization Wires
• Procedure Trays
• Others

Biopsy Device Market by Guidance Technique [Analysis by Value from 2018 to 2030]:

• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• MRI-Guided Biopsy
• Others

Biopsy Device Market by Application [Analysis by Value from 2018 to 2030]:

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

Biopsy Device Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Academic and Research Institutes
• Diagnostic and Imaging Centers

Biopsy Device Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biopsy Device Market

The latest trends in biopsy devices reflect overall developments in the medical device domain, emphasizing accuracy, minimization of invasiveness, and integration of digital features. These enhancements are poised to improve diagnostic and therapeutic activities worldwide.

• United States: In the U.S., biopsy devices have advanced significantly, particularly in robotic surgical systems. For example, the technological advancements by Intuitive Surgical and Medtronic have focused on precision and minimizing patient discomfort. Technologies incorporating AI to analyze images for diagnostic purposes have also been developed. These innovations improve biopsy procedures, reduce procedural risks, and shorten patient recovery times.
• China: China's biopsy device market is expanding beyond simple biopsy techniques to incorporate artificial intelligence into device designs. Many companies are offering equipment that employs AI principles to sample tissues more accurately. Additionally, efforts are being made to make these technologies affordable, ensuring accessibility for rural populations. Advances in healthcare device manufacturing in China are improving public health and increasing access to high-quality diagnostics.
• Germany: Germany leads in the development of advanced biopsy technologies, focusing on accuracy and automation. The emergence of multifunctional, high-resolution imaging systems and automated biopsy devices is reducing the likelihood of human error. German companies are also working on integrating biopsy devices with electronic health records to improve clinical management. These advancements are streamlining biopsy processes, enhancing efficiency, and improving healthcare quality in both clinical and research settings.
• India: In India, new biopsy devices are evolving to include affordable and lightweight options suitable for diverse work environments. Companies and research institutions are developing low-cost biopsy technologies that can be utilized in rural areas and are user-friendly. This focus on affordability and ease of use aims to enhance early cancer detection and address healthcare challenges in many parts of the country.
• Japan: Japan is advancing biopsy devices equipped with modern imaging and robotic technologies. Japanese industries are developing systems that offer real-time imaging and robotic assistance to facilitate biopsy procedures. There are also efforts to integrate these systems with telemedicine platforms for remote consultation and diagnosis. These initiatives aim to improve diagnostic accuracy and effectiveness while ensuring robust health technology within Japan's healthcare system.

Features of the Global Biopsy Device Market

Market Size Estimates: Biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopsy device market size by various segments, such as by product, guidance technique, application, end use, and region in terms of value ($B).

Regional Analysis: Biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, guidance techniques, applications, end uses, and regions for the biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopsy device market by product (needle-based biopsy devices, localization wires, procedure trays, and others), guidance technique (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others), application (breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others), end use (hospitals, academic and research institutes, and diagnostic and imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Biopsy Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopsy Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopsy Device Market by Product
  • 3.3.1: Needle-Based Biopsy Devices
  • 3.3.2: Localization Wires
  • 3.3.3: Procedure Trays
  • 3.3.4: Others
• 3.4: Global Biopsy Device Market by Guidance Technique
  • 3.4.1: Ultrasound-Guided Biopsy
  • 3.4.2: Stereotactic-Guided Biopsy
  • 3.4.3: MRI-Guided Biopsy
  • 3.4.4: Others
• 3.5: Global Biopsy Device Market by Application
  • 3.5.1: Breast Biopsy
  • 3.5.2: Lung Biopsy
  • 3.5.3: Colorectal Biopsy
  • 3.5.4: Prostate Biopsy
  • 3.5.5: Others
• 3.6: Global Biopsy Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Academic and Research Institutes
  • 3.6.3: Diagnostic and Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopsy Device Market by Region
• 4.2: North American Biopsy Device Market
  • 4.2.1: North American Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.2.2: North American Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.3: European Biopsy Device Market
  • 4.3.1: European Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.3.2: European Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.4: APAC Biopsy Device Market
  • 4.4.1: APAC Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.4.2: APAC Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.5: ROW Biopsy Device Market
  • 4.5.1: ROW Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.5.2: ROW Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopsy Device Market by Product
  • 6.1.2: Growth Opportunities for the Global Biopsy Device Market by Guidance Technique
  • 6.1.3: Growth Opportunities for the Global Biopsy Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Biopsy Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Biopsy Device Market by Region
• 6.2: Emerging Trends in the Global Biopsy Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopsy Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopsy Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cook Medical
• 7.2: Boston Scientific
• 7.3: Fujifilm
• 7.4: Cardinal Health
• 7.5: Danaher